Protective effects of nicotinamide riboside on H2O2-induced oxidative damage in lens epithelial cells Sensory, PreclinicalANAD StaffDecember 9, 2020Sensory
Deletion of CD38 and supplementation of NAD+ attenuate axon degeneration in a mouse facial nerve axotomy model Sensory, PreclinicalANAD StaffOctober 20, 2020Sensory
Hyperglycemia-reduced NAD+ biosynthesis impairs corneal epithelial wound healing in diabetic mice Sensory, PreclinicalANAD StaffOctober 11, 2020Sensory
Implications of NAD+ Metabolism in the Aging Retina and Retinal Degeneration Sensory, Aging, ReviewANAD StaffMay 11, 2020Review, Aging, Sensory
Nicotinamide riboside protects noise-induced hearing loss by recovering the hair cell ribbon synapses Sensory, PreclinicalANAD StaffMarch 19, 2020Sensory
Short-term NAD+ supplementation prevents hearing loss in mouse models of Cockayne syndrome Preclinical Research, SensoryANAD StaffJanuary 7, 2020
NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy Clinical Studies, Sensory, RecruitingANAD StaffOctober 2, 2019
Evaluation of Nicotinamide Riboside in Prevention of small Fiber Axon Degeneration and Promotion of Nerve Regeneration Clinical Studies, Sensory, Not Yet RecruitingANAD StaffApril 11, 2019
Nicotinamide Riboside for Diabetic Neuropathy Clinical Studies, Sensory, RecruitingANAD StaffSeptember 26, 2018
NR in Chemo-induced Peripheral Neuropathy Clinical Studies, Sensory, RecruitingANAD StaffAugust 22, 2018
Nicotinamide Riboside, a Form of Vitamin B 3, Protects Against Excitotoxicity-Induced Axonal Degeneration Preclinical Research, SensoryANAD StaffAugust 24, 2017
Nicotinamide riboside, a form of vitamin B3 and NAD+ precursor, relieves the nociceptive and aversive dimensions of paclitaxel-induced peripheral neuropathy in female rats Preclinical Research, SensoryANAD StaffMay 15, 2017
